Skip to content

Homoeopathic treatment of heavy menstrual bleeding

Efficacy of individualized homoeopathic medicines in the treatment of heavy menstrual bleeding of reproductive females: A Double-blind, randomized, placebo-controlled trial - Nil

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078220
Enrollment
66
Registered
2024-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle Health Condition 2: N921- Excessive and frequent menstruation with irregular cycle

Interventions

Intervention1: Individualized homoeopathic medicines in individualized dosage in centesimal potencies plus concomitant care: The enrolled patients of HMB will be treated with IHMs. Administering recom
dosage and frequency to be determined by the specific needs of each case. Within 30 minutes of consuming the globules, patients will be instructed not to handle the globules, nor to eat, drink, smoke,

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age- reproductive females between 13 and 40 years. 2.Patients of mild and moderate cases of heavy menstrual bleeding assessed by PBAC score between 100 and 185. 3.Participants who can clearly understand and fill the Pictorial blood loss assessment chart questionnaires.

Exclusion criteria

Exclusion criteria: 1. Failing to give written, informed consent or assent before participating. 2. Cases of Malignancy (M), Coagulopathy (C), Ovulatory cause (O), Iatrogenic (I), Not otherwise classified (N) as per Figo classification of PALM-COEIN. 3. Hemoglobin less than 7 gm /dl. 4. Suffering from any uncontrolled systemic diseases like diabetes, hypertension, thyroid disorders, etc. 5. Women having leiomyoma size of 5 cm or more. 6. Women who are planning for child within 1 year. 7. Patient undergoing any hormonal replacement therapy, using contraceptive pills, intra uterine devices or history of their use in previous 3 months. 8. Those who are too ill to get consultation. 9. Diagnosed cases of uncontrolled or potentially fatal illnesses impacting quality of life, such as unstable mental or psychiatric illnesses. 10. Lactating mothers and women in puerperal states. 11. AIDS, hepatitis, and other self-reported immune weakened states. 12. Receiving homeopathic treatment within the last 3 months for any chronic illness. 13. Concurrent involvement in any other clinical study. 14. The requirement for further procedures in addition to surgery. 15. Chewing tobacco, smoking, alcoholism, any kind of substance addiction, abuse, and/or dependence (TAPS tool).

Design outcomes

Primary

MeasureTime frame
Pictorial Blood Loss Assessment Chart (PBAC)Timepoint: Baseline, 4 weeks, and 8 weeks

Countries

India

Contacts

Public ContactSubhasish Ganguly

D N De Homoeopathic Medical College and Hospital

dr.subhasish67@gmail.com9007263548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026